-
1
-
-
79955671043
-
Targeting oligomers in neurodegenerative disorders: Lessons from α-synuclein, tau, and amyloid-β peptide
-
Gadad BS, Britton GB, Rao KS (2011) Targeting oligomers in neurodegenerative disorders: lessons from α-synuclein, tau, and amyloid-β peptide. J Alzheimers Dis 24(Suppl 2):223-232
-
(2011)
J Alzheimers Dis
, vol.24
, Issue.SUPPL. 2
, pp. 223-232
-
-
Gadad, B.S.1
Britton, G.B.2
Rao, K.S.3
-
2
-
-
44849084558
-
Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers
-
Kostka M, Hogen T, Danzer KM, Levin J, Habeck M, Wirth A, Wagner R, Glabe CG, Finger S, Heinzelmann U, Garidel P, Duan W, Ross CA, Kretzschmar H, Giese A (2008) Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers. J Biol Chem 283:10992-11003
-
(2008)
J Biol Chem
, vol.283
, pp. 10992-11003
-
-
Kostka, M.1
Hogen, T.2
Danzer, K.M.3
Levin, J.4
Habeck, M.5
Wirth, A.6
Wagner, R.7
Glabe, C.G.8
Finger, S.9
Heinzelmann, U.10
Garidel, P.11
Duan, W.12
Ross, C.A.13
Kretzschmar, H.14
Giese, A.15
-
3
-
-
70350338222
-
Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models
-
Karpinar DP, Balija MB, Kügler S, Opazo F, Rezaei-Ghaleh N, Wender N, Kim HY, Taschenberger G, Falkenburger BH, Heise H, Kumar A, Riedel D, Fichtner L, Voigt A, Braus GH, Giller K, Becker S, Herzig A, Baldus M, Jäckle H, Eimer S, Schulz JB, Griesinger C, Zweckstetter M (2009) Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models. EMBO J 28:3256-3268
-
(2009)
EMBO J
, vol.28
, pp. 3256-3268
-
-
Karpinar, D.P.1
Balija, M.B.2
Kügler, S.3
Opazo, F.4
Rezaei-Ghaleh, N.5
Wender, N.6
Kim, H.Y.7
Taschenberger, G.8
Falkenburger, B.H.9
Heise, H.10
Kumar, A.11
Riedel, D.12
Fichtner, L.13
Voigt, A.14
Braus, G.H.15
Giller, K.16
Becker, S.17
Herzig, A.18
Baldus, M.19
Jäckle, H.20
Eimer, S.21
Schulz, J.B.22
Griesinger, C.23
Zweckstetter, M.24
more..
-
4
-
-
0036855635
-
Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies
-
DOI 10.1172/JCI200215777
-
Neumann M, Kahle PJ, Giasson BI, Ozmen L, Borroni E, Spooren W, Muller V, Odoy S, Fujiwara H, Hasegawa M, Iwatsubo T, Trojanowski JQ, Kretzschmar HA, Haass C (2002) Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies. J Clin Investig 110:1429-1439 (Pubitemid 35396914)
-
(2002)
Journal of Clinical Investigation
, vol.110
, Issue.10
, pp. 1429-1439
-
-
Neumann, M.1
Kahle, P.J.2
Giasson, B.I.3
Ozmen, L.4
Borroni, E.5
Spooren, W.6
Muller, V.7
Odoy, S.8
Fujiwara, H.9
Hasegawa, M.10
Iwatsubo, T.11
Trojanowski, J.Q.12
Kretzschmar, H.A.13
Haass, C.14
-
5
-
-
84878587404
-
Anle138b: A novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease
-
Wagner J, Ryazanov S, Leonov A, Levin J, Shi S, Schmidt F, Prix C, Pan-Montojo F, Bertsch U, Mitteregger-Kretzschmar G, Geissen M, Eiden M, Leidel F, Hirschberger T, Deeg AA, Krauth JJ, Zinth W, Tavan P, Pilger J, Zweckstetter M, Frank T, Bähr M, Weishaupt J, Uhr M, Urlaub H, Teichmann U, Samwer M, Bötzel K, Groschup M, Kretzschmar H, Griesinger C, Giese A (2013) Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease. Acta Neuropathol 125:795-813
-
(2013)
Acta Neuropathol
, vol.125
, pp. 795-813
-
-
Wagner, J.1
Ryazanov, S.2
Leonov, A.3
Levin, J.4
Shi, S.5
Schmidt, F.6
Prix, C.7
Pan-Montojo, F.8
Bertsch, U.9
Mitteregger-Kretzschmar, G.10
Geissen, M.11
Eiden, M.12
Leidel, F.13
Hirschberger, T.14
Deeg, A.A.15
Krauth, J.J.16
Zinth, W.17
Tavan, P.18
Pilger, J.19
Zweckstetter, M.20
Frank, T.21
Bähr, M.22
Weishaupt, J.23
Uhr, M.24
Urlaub, H.25
Teichmann, U.26
Samwer, M.27
Bötzel, K.28
Groschup, M.29
Kretzschmar, H.30
Griesinger, C.31
Giese, A.32
more..
|